Open an account

Oddity Tech

ODD · NASDAQ

$22.65−$0.70 (−3.00%)TodayMarket closed ·
Prev close $23.35

About ODD

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. The company employs 658 full-time employees The company went IPO on 2023-07-19. The firm is operating a tech platform under its own brand on the Internet, whose purpose is to support a portfolio of brands and services connected to the beauty and wellness market and to develop products customized to the wishes of the Company's clients. The firm is using algorithms and machine learning models to match a corresponding physical product. Advanced biological models and machine learning-based tools are used to find new molecules for beauty and wellness purposes. The firm is active in research and development in areas such as data science, machine learning, and computer vision to enhance its products.

Employees
658
Headquarters
TEL AVIV-YAFO
Listed
Jul 19, 2023
Sector
Consumer Staples
Industry
Personal Care Products
Website
oddity.com

ODD key statistics

Market cap
1.04B
Price-earnings ratio
97.29
Dividend yield
—
Average volume
708.18K
Volume
461.03K
Open price
$23.02
High today
$23.39
Low today
$22.60
52 Week high
$49.29
52 Week low
$9.25

Oddity Tech (ODD) at a glance

Oddity Tech (ODD) last traded at $22.65, with a market cap of 1.04B and a price-to-earnings ratio of 97.29.

Today the stock has traded between $22.60 and $23.39. The current price is 0.2% above the day's low and 3.2% below its high.

Volume so far is 461.03K shares, below the average of 708.18K shares a day.

Over the past year Oddity Tech has ranged from $9.25 to $49.29, and now sits 33% of the way up that range.

Oddity Tech met or beat analyst EPS estimates in 7 of the last 8 quarters. In Q2 FY26 it reported $0.20 per share against an estimate of $0.1616.

ODD earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 27.1% on average.

  1. Q3 FY24: reported $0.32 per share against an estimate of $0.2326
  2. Q4 FY24: reported $0.20 per share against an estimate of $0.1314
  3. Q1 FY25: reported $0.69 per share against an estimate of $0.6295
  4. Q2 FY25: reported $0.92 per share against an estimate of $0.8842
  5. Q3 FY25: reported $0.40 per share against an estimate of $0.3495
  6. Q4 FY25: reported $0.20 per share against an estimate of $0.1353
  7. Q1 FY26: reported -$0.17 per share against an estimate of -$0.0202
  8. Q2 FY26: reported $0.20 per share against an estimate of $0.1616

ODD news

  • Lekha Gupta

    Short Squeeze And Earnings: Why ODDITY Tech Stock Spiked Wednesday

  • Avi Kapoor

    Crude Oil Jumps Over 3%; Core & Main Posts Upbeat Q2 Earnings

  • Market-Moving News for September 9th

  • Priya Nigam

    Oddity Tech Q2 Earnings Preview: Expect CPA Pressure With Early Inflection Signs

  • Press releasePRNewswire

    ODD 9-DAY DEADLINE ALERT: ODDITY Tech. (ODD) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action - Hagens Berman

  • Press releasePRNewswire

    ODD DEADLINE ALERT: Hagens Berman Alerts ODDITY Tech. (ODD) Investors to Today's Lead Plaintiff Deadline in Securities Class Action

  • Press releaseBusiness Wire

    ODD CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Oddity Tech (ODD) Investors of Securities Class Action Deadline on May 11, 2026

  • Press releaseGlobe Newswire

    ODD FINAL DEADLINE ALERT: ODDITY Tech. (ODD) Shares Crater 49% Amid "Dislocation" Issue and Expected 30% Decline in Revenue; Securities Class Action Pending -- Hagens Berman

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.